Litcius/Paper detail

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Shoujie Huang, Xuefeng Zhang, Yingying Su, Chunlan Zhuang, Zimin Tang, Xingcheng Huang, Qi Chen, Kongxin Zhu, Xiaowen Hu, Ying Dong, Xiaohui Liu, Han-Min Jiang, Xia Zang, Zhongze Wang, Changlin Yang, Donglin Liu, Yijun Wang, Quan Tang, Wentong Shen, Huanhuan Cao, Huirong Pan, Shengxiang Ge, Yue Huang, Ting Wu, Zizheng Zheng, Fengcai Zhu, Jun Zhang, Ningshao Xia

2024The Lancet70 citationsDOI

Topics & Concepts

MedicinePlaceboDouble blindHepatitis A vaccineHepatitis AVirologyHepatitisTerm (time)Hepatitis a virusRandomized controlled trialInternal medicineVirusAlternative medicinePathologyPhysicsQuantum mechanicsHepatitis Viruses Studies and EpidemiologyViral Infections and Immunology ResearchTravel-related health issues